As shown in Fig. 8F and G, the depletion of CD8+T cells significantly impaired the anti-tumor efficacy of the combination therapy, whereas CD4 T cells depletion exerted no significant effect on the therapeutic effect of CAR-Ms and oAd-CD47. This evidence concerns the gene CD47 and neoplasm.